Michael Kalos, Ph.D., is the founder and managing director of Next Pillar Consulting, where he advises biopharmaceutical and venture organizations. He is also a Venture Partner with Alloy Therapeutics ...

Advancements in genome editing technologies the growing emphasis on safe and accurate gene correction, and strong biotechnology R&D investment drive the base editing market.Austin, Texas, Jan. 21, ...

Growing focus on gene-based therapies, advances in editing tools, and increasing research investments are accelerating the adoption of genome editing technologies across life sciences and agriculture.

Heyink also has Lynch syndrome, and since around age 20, he's gotten an annual colonoscopy and an endoscopy every other year ...

Spina bifida and anencephaly are neural tube defects caused by failure of embryonic neural tube closure. Successful closure requires apicobasal elongation and apical constriction of neuroepithelial ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward ...

The 67,800-year-old hand stencil looks like a claw—and provides new clues about early human cognition and the migration to ...

China’s agritech industry is central to modernizing the sector and bolstering food security, creating new opportunities for ...

Brazilian researchers have identified previously unknown forms of a protein linked to breast cancer. The discovery ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. Today, for instance, pharmaceutical companies use ...

Chicken growth is not due to hormones or steroids, but rather advanced breeding and genetics, better nutrition, veterinary ...

The strategy, known as synthetic biology, is gaining momentum globally as a conservation tool and human health solution, ...